Taken together, we confirmed the aberrant expression of surface proteins FIBG, PDGF-β, and TGF-β on serum-derived EVs in CRC patients through rigorous analysis of a large-scale sample cohort. This evidence concerns the gene TGFB1 and colorectal carcinoma.